scholarly journals Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss

2021 ◽  
Vol 8 (1) ◽  
pp. e000980
Author(s):  
Vasilis Nikolaou ◽  
Sebastiano Massaro ◽  
Wolfgang Garn ◽  
Masoud Fakhimi ◽  
Lampros Stergioulas ◽  
...  

BackgroundChronic obstructive pulmonary disease (COPD) is a heterogeneous group of lung conditions challenging to diagnose and treat. Identification of phenotypes of patients with lung function loss may allow early intervention and improve disease management. We characterised patients with the ‘fast decliner’ phenotype, determined its reproducibility and predicted lung function decline after COPD diagnosis.MethodsA prospective 4 years observational study that applies machine learning tools to identify COPD phenotypes among 13 260 patients from the UK Royal College of General Practitioners and Surveillance Centre database. The phenotypes were identified prior to diagnosis (training data set), and their reproducibility was assessed after COPD diagnosis (validation data set).ResultsThree COPD phenotypes were identified, the most common of which was the ‘fast decliner’—characterised by patients of younger age with the lowest number of COPD exacerbations and better lung function—yet a fast decline in lung function with increasing number of exacerbations. The other two phenotypes were characterised by (a) patients with the highest prevalence of COPD severity and (b) patients of older age, mostly men and the highest prevalence of diabetes, cardiovascular comorbidities and hypertension. These phenotypes were reproduced in the validation data set with 80% accuracy. Gender, COPD severity and exacerbations were the most important risk factors for lung function decline in the most common phenotype.ConclusionsIn this study, three COPD phenotypes were identified prior to patients being diagnosed with COPD. The reproducibility of those phenotypes in a blind data set following COPD diagnosis suggests their generalisability among different populations.

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Yilan Sun ◽  
Stephen Milne ◽  
Jen Erh Jaw ◽  
Chen Xi Yang ◽  
Feng Xu ◽  
...  

Abstract Background There is considerable heterogeneity in the rate of lung function decline in chronic obstructive pulmonary disease (COPD), the determinants of which are largely unknown. Observational studies in COPD indicate that low body mass index (BMI) is associated with worse outcomes, and overweight/obesity has a protective effect – the so-called “obesity paradox”. We aimed to determine the relationship between BMI and the rate of FEV1 decline in data from published clinical trials in COPD. Methods We performed a systematic review of the literature, and identified 5 randomized controlled trials reporting the association between BMI and FEV1 decline. Four of these were included in the meta-analyses. We analyzed BMI in 4 categories: BMI-I (< 18.5 or <  20 kg/m2), BMI-II (18.5 or 20 to < 25 kg/m2), BMI-III (25 to < 29 or < 30 kg/m2) and BMI-IV (≥29 or ≥ 30 kg/m2). We then performed a meta-regression of all the estimates against the BMI category. Results The estimated rate of FEV1 decline decreased with increasing BMI. Meta-regression of the estimates showed that BMI was significantly associated with the rate of FEV1 decline (linear trend p = 1.21 × 10− 5). Conclusions These novel findings support the obesity paradox in COPD: compared to normal BMI, low BMI is a risk factor for accelerated lung function decline, whilst high BMI has a protective effect. The relationship may be due to common but as-of-yet unknown causative factors; further investigation into which may reveal novel endotypes or targets for therapeutic intervention.


Nutrients ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 1357 ◽  
Author(s):  
Egeria Scoditti ◽  
Marika Massaro ◽  
Sergio Garbarino ◽  
Domenico Maurizio Toraldo

Chronic obstructive pulmonary disease is one of the leading causes of morbidity and mortality worldwide and a growing healthcare problem. Identification of modifiable risk factors for prevention and treatment of COPD is urgent, and the scientific community has begun to pay close attention to diet as an integral part of COPD management, from prevention to treatment. This review summarizes the evidence from observational and clinical studies regarding the impact of nutrients and dietary patterns on lung function and COPD development, progression, and outcomes, with highlights on potential mechanisms of action. Several dietary options can be considered in terms of COPD prevention and/or progression. Although definitive data are lacking, the available scientific evidence indicates that some foods and nutrients, especially those nutraceuticals endowed with antioxidant and anti-inflammatory properties and when consumed in combinations in the form of balanced dietary patterns, are associated with better pulmonary function, less lung function decline, and reduced risk of COPD. Knowledge of dietary influences on COPD may provide health professionals with an evidence-based lifestyle approach to better counsel patients toward improved pulmonary health.


2016 ◽  
Vol 188 (14) ◽  
pp. 1004-1011 ◽  
Author(s):  
Zafar Zafari ◽  
Don D. Sin ◽  
Dirkje S. Postma ◽  
Claes-Göran Löfdahl ◽  
Judith Vonk ◽  
...  

2020 ◽  
Author(s):  
Shigeo Muro ◽  
Masato Ishida ◽  
Yoshiharu Horie ◽  
Wataru Takeuchi ◽  
Shunki Nakagawa ◽  
...  

BACKGROUND Airflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances including tobacco smoke is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist. OBJECTIVE To predict risk factors for COPD diagnosis using machine learning in an annual medical check-up database. METHODS In this retrospective, observational cohort study (Analysis of Risk factors To DEtect COPD [ARTDECO]), annual medical check-up records for all Hitachi Ltd. employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30–75 years, without prior diagnosis of COPD, asthma, or history of cancer were included. The database included clinical measurements (e.g., pulmonary function tests) and questionnaire responses. To predict risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning method (XGBoost) was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the pre-bronchodilator forced expiratory volume in 1 second (FEV1) to pre-bronchodilator forced vital capacity (FVC) was <0.7 during two consecutive examinations. RESULTS Of the 26,101 individuals screened, 1,213 met the exclusion criteria and thus 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV1/FVC, smoking status, allergic symptoms, cough, pack years, hemoglobin A1c, serum albumin, mean corpuscular volume, percent predicted vital capacity value, and percent predicted value of FEV1. The area under the receiver operating characteristic curves of the XGBoost model and the logistic regression model were 0.956 and 0.943, respectively. CONCLUSIONS Using a machine learning model in this longitudinal database, we identified a set multiple of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan. CLINICALTRIAL Not applicable.


Sign in / Sign up

Export Citation Format

Share Document